Covetrus Inc.

20.99
0.00 (0.00%)
At close: Oct 12, 2022, 8:00 PM

Company Description

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company.

It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers.

The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners.

In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics.

Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services.

It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific.

The company was formerly known as HS Spinco, Inc.

Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.

As of October 13, 2022, Covetrus, Inc. was taken private.

Covetrus Inc.
Covetrus Inc. logo
Country United States
IPO Date Feb 4, 2019
Industry Medical - Distribution
Sector Healthcare
Employees 4,035
CEO Benjamin Wolin

Contact Details

Address:
7 Custom House St
Portland, MAINE
United States
Website https://www.covetrus.com

Stock Details

Ticker Symbol CVET
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001752836
CUSIP Number 22304C100
ISIN Number US22304C1009
Employer ID 83-1448706
SIC Code 5912

Key Executives

Name Position
Benjamin Wolin Pres, Chief Executive Officer & Director
Matthew J. Foulston Executive Vice President & Global Chief Financial Officer
Michelle Bonfilio Chief People Officer
Andrew B. Coxhead Vice President, Corporation Controller & Chief Accounting Officer
Cameron R. Foster Senior Vice President of Strategy & Corporation Devel.
Georgina Wraight Executive Vice President & Pres of Global Technology Solutions
Margie B. Pritchard Gen. Counsel & Corporation Sec.
Matthew Malenfant Chief Commercial Officer
Nicholas Michael Jansen Vice President of Investor Relations
Rebecca Kidd Head of Operations & Operational Excellence

Latest SEC Filings

Date Type Title
Oct 24, 2022 15-12G Filing
Oct 13, 2022 SC 13D/A [Amend] Filing
Oct 13, 2022 4 Filing
Oct 13, 2022 S-8 POS Filing
Oct 13, 2022 SC 13E3/A [Amend] Filing
Oct 13, 2022 8-K Current Report
Oct 13, 2022 4 Filing
Oct 13, 2022 4 Filing
Oct 13, 2022 4 Filing
Oct 13, 2022 4 Filing